Piruorette Pharma

Pirouette Pharma is reimagining the auto-injector to make life-saving injections as simple as pushing a button. Their patented, disk-shaped device is designed for intuitive use, eliminating needle visibility and reducing the anxiety often associated with self-administration. Compact, rugged, and pre-filled, the injector is built for real-world emergencies—whether it’s anaphylaxis, opioid overdose, or other critical conditions.

The company’s first products, QuicPush (epinephrine) and RezqGo (naloxone), target urgent public health needs with a focus on affordability and ease of use. Unlike traditional auto-injectors, Pirouette’s platform is designed to be compatible with a wide range of injectable drugs, from hormone therapies to chronic disease treatments, offering a scalable solution for both emergency and routine care.

Founded by engineers from Clarkson University and MIT, the Pirouette team brings deep expertise from aerospace, medical devices, and FDA-regulated industries. Backed by Founders Inc, Y Combinator, Safar Partners, and NIH SEED, Pirouette is on a mission to place healthcare in the hands of the patient—literally—by transforming how injections are delivered across a $1T+ global market.